Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials (Q48692404)

14 February 2018

title

Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials (English)

1 reference

14 February 2018

0 references

1

Ralph H B Benedict

1 reference

14 February 2018

author name string

Audrey Smerbeck

2

1 reference

14 February 2018

Rajavi Parikh

3

1 reference

14 February 2018

Jonathan Rodgers

4

1 reference

14 February 2018

Diego Cadavid

5

1 reference

14 February 2018

David Erlanger

6

1 reference

14 February 2018

publication date

25 January 2012

1 reference

14 February 2018

Multiple Sclerosis Journal

published in

1 reference

14 February 2018

volume

18

1 reference

14 February 2018

issue

9

1 reference

14 February 2018

page(s)

1320-1325

1 reference

14 February 2018

Risk factors for and management of cognitive dysfunction in multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Cognitive impairment and structural brain damage in benign multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Self-generation to improve learning and memory of functional activities in persons with multiple sclerosis: meal preparation and managing finances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Paced auditory serial-addition task: a measure of recovery from concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Three screening batteries to detect cognitive impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Personality disorder in multiple sclerosis correlates with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

A semiautomated measure of whole-brain atrophy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Donepezil improved memory in multiple sclerosis in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

L-amphetamine improves memory in MS patients with objective memory impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Effects of acute relapses on neuropsychological status in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511435717

21 January 2018

Identifiers

DOI

10.1177/1352458511435717

1 reference

14 February 2018

1 reference

14 February 2018